Company registration number 06836256 (England and Wales)
MEDGENESIS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
PAGES FOR FILING WITH REGISTRAR
MEDGENESIS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MEDGENESIS LIMITED
BALANCE SHEET
AS AT 31 MAY 2025
31 May 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
86,752
128,875
Tangible assets
4
1,053
1,920
87,805
130,795
Current assets
Debtors
5
10,220
33,018
Cash at bank and in hand
100,989
123,234
111,209
156,252
Creditors: amounts falling due within one year
6
(46,854)
(117,865)
Net current assets
64,355
38,387
Total assets less current liabilities
152,160
169,182
Provisions for liabilities
2,766
(365)
Net assets
154,926
168,817
Capital and reserves
Called up share capital
7
15,335
15,334
Profit and loss reserves
139,591
153,483
Total equity
154,926
168,817

The notes on pages 3 to 7 form part of these financial statements.

MEDGENESIS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MAY 2025
31 May 2025
- 2 -

For the financial year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 6 November 2025 and are signed on its behalf by:
Mr M Marks
Director
Company registration number 06836256 (England and Wales)
MEDGENESIS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
- 3 -
1
Accounting policies
Company information

Medgenesis Limited is a private company limited by shares incorporated in England and Wales. The registered office is 105 Great North Road, Eaton Socon, St Neots, Cambs, PE19 8EL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
5 years straight line
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
15% reducing balance
Computer equipment
3 years straight line
MEDGENESIS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 4 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

MEDGENESIS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Government grants

Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.12
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

MEDGENESIS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
3
Intangible fixed assets
Software
£
Cost
At 1 June 2024
315,510
Additions
26,224
At 31 May 2025
341,734
Amortisation and impairment
At 1 June 2024
186,635
Amortisation charged for the year
68,347
At 31 May 2025
254,982
Carrying amount
At 31 May 2025
86,752
At 31 May 2024
128,875
4
Tangible fixed assets
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
Cost
At 1 June 2024 and 31 May 2025
750
6,889
7,639
Depreciation and impairment
At 1 June 2024
477
5,242
5,719
Depreciation charged in the year
41
826
867
At 31 May 2025
518
6,068
6,586
Carrying amount
At 31 May 2025
232
821
1,053
At 31 May 2024
273
1,647
1,920
MEDGENESIS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 7 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
5,902
4,769
Corporation tax recoverable
-
0
942
Other debtors
2,148
25,237
Prepayments
2,170
2,070
10,220
33,018
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
-
0
600
Taxation and social security
-
0
930
Deferred income
13,563
18,429
Other creditors
29,871
94,921
Accruals
3,420
2,985
46,854
117,865
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A Shares of 0.0125p each
1,226,763
1,226,763
15,335
15,334
8
Related party transactions

During the year, Medgenesis Ltd received goods and services of £108,537 (2024: £148,495) from related parties, of which £13,933 (2024: £12,317) is owed at the year end. These companies are related through the sharing of director M Marks.

At the year-end, Medgenesis Ltd is owed £0 (202 4: £22,532) from related parties. These amounts are relating to an interest free loan, which is repayable on demand. The loan has been provided by a company which is owned by a controlling director; M Marks.

2025-05-31 2024-06-01 false false false 06 November 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr S Bentley Mr M Marks Mrs A Bentley 06836256 2024-06-01 2025-05-31 06836256 2025-05-31 06836256 2024-05-31 06836256 core:ComputerSoftware 2025-05-31 06836256 core:ComputerSoftware 2024-05-31 06836256 core:FurnitureFittings 2025-05-31 06836256 core:ComputerEquipment 2025-05-31 06836256 core:FurnitureFittings 2024-05-31 06836256 core:ComputerEquipment 2024-05-31 06836256 core:ShareCapital 2025-05-31 06836256 core:ShareCapital 2024-05-31 06836256 core:RetainedEarningsAccumulatedLosses 2025-05-31 06836256 core:RetainedEarningsAccumulatedLosses 2024-05-31 06836256 core:ShareCapitalOrdinaryShareClass1 2025-05-31 06836256 core:ShareCapitalOrdinaryShareClass1 2024-05-31 06836256 bus:Director2 2024-06-01 2025-05-31 06836256 core:IntangibleAssetsOtherThanGoodwill 2024-06-01 2025-05-31 06836256 core:ComputerSoftware 2024-06-01 2025-05-31 06836256 core:FurnitureFittings 2024-06-01 2025-05-31 06836256 core:ComputerEquipment 2024-06-01 2025-05-31 06836256 2023-06-01 2024-05-31 06836256 core:ComputerSoftware 2024-05-31 06836256 core:ComputerSoftware core:ExternallyAcquiredIntangibleAssets 2024-06-01 2025-05-31 06836256 core:FurnitureFittings 2024-05-31 06836256 core:ComputerEquipment 2024-05-31 06836256 2024-05-31 06836256 core:CurrentFinancialInstruments 2025-05-31 06836256 core:CurrentFinancialInstruments 2024-05-31 06836256 bus:OrdinaryShareClass1 2025-05-31 06836256 bus:OrdinaryShareClass1 2024-05-31 06836256 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 06836256 bus:FRS102 2024-06-01 2025-05-31 06836256 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 06836256 bus:Director1 2024-06-01 2025-05-31 06836256 bus:CompanySecretary1 2024-06-01 2025-05-31 06836256 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 06836256 bus:FullAccounts 2024-06-01 2025-05-31 xbrli:pure xbrli:shares iso4217:GBP